Ticagrelor is used along with low-dose aspirin to help prevent heart attack and stroke in people with a history of heart disease, stroke, or at increased risk for heart disease or stroke (for example, due to diabetes, history of transient ischemic attack-TIA). It may also prevent blood clots after certain heart surgeries (such as stent placement).
Ticagrelor works by blocking platelets from sticking together and prevents them from forming harmful clots. It is an antiplatelet drug. It keeps blood flowing smoothly in your body.
Are you looking for or in search of FDA approved “ticagrelor tablets for oral use in India”? “Medicant Healthcare” a registered pharmacy firm in India deals in both brand name as well as generic name Drugs / medicine approved for Cardiovascular. Need Access of “ticagrelor tablets for oral use” get in touch with our healthcare professional.
BRILINTA is a P2Y12 platelet inhibitor indicated
• to reduce the risk of cardiovascular (CV) death, myocardial infarction (MI), and stroke in patients with acute coronary syndrome (ACS) or a history of MI. For at least the first 12 months following ACS, it is superior to clopidogrel. BRILINTA also reduces the risk of stent thrombosis in patients who have been stented for treatment of ACS.
• to reduce the risk of a first MI or stroke in patients with coronary artery disease (CAD) at high risk for such events. While use is not limited to this setting, the efficacy of BRILINTA was established in a population with type 2 diabetes mellitus (T2DM).
• to reduce the risk of stroke in patients with acute ischemic stroke (NIH Stroke Scale score ≤5) or high-risk transient ischemic attack (TIA). \
ticagrelor tablets for oral use
Contact No.
Call us
+91 11 4350 7259
Emergency Contact
+91 93139 48015
Address
Visit us anytime
F-90/1 , Okhla Industrial Area,
Phase -1 , New Delhi. India
Send us an email
medicanthealthcare@outlook.com
info@medicanthealthcare.com